SOURCE: Celsion Corporation

Celsion Corporation

March 01, 2011 08:00 ET

Celsion to Present at Cowen and Company 31st Annual Health Care Conference

COLUMBIA, MD--(Marketwire - March 1, 2011) -  Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion's President and Chief Executive Officer, will be presenting at the Cowen and Company 31st Annual Health Care Conference on Tuesday, March 8th at 11:00 A.M. Eastern Time, at the Boston Marriott Copley Place in Boston, Massachusetts.

A live webcast of the presentation will be available on Celsion's website at http://www.celsion.com/events.cfm. The webcast will be archived on the same site for replay following the conference.

About Celsion

Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Mayo Clinic, the University of Pisa, and the North Shore Long Island Jewish Health System.

For more information on Celsion, visit our website: http://www.celsion.com.

Contact Information

  • Investor Contact
    David Pitts
    Argot Partners
    212-600-1902
    Email Contact